| Term 
 | Definition 
 
        | 1) amnesia - occurs through depressing neuronal activity 2) immobility in response to noxious stimuliation - inhibiting concious brain activity or nerve reflexes;
 3) attenuation of autonomic response to noxious stimuli
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | use of multiple drugs to achieve desired depth of aneshtesia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | barbiturates, diazepam, midazolam, atropine (blocks ACh effect on heart), 5-HT3 receptor antagonist (ondansetron - prevent vomiting), H-2 antagonist (ranitidine - acid reflux) |  | 
        |  | 
        
        | Term 
 
        | Intravenous GAs - sodiuim thiopental [Pentothal], propofol [Diprivan], etomidate [Amidate], ketamine [Ketalar] |  | Definition 
 
        | used to induce anesthesia - faster acting |  | 
        |  | 
        
        | Term 
 
        | Inhaled GAs - nitrous oxide [N2O], halothane [Fluothane], isoflurane [Forane], enflurane [Ethrane], desflurane [Suprane], sevoflurane [Ultane] |  | Definition 
 
        | used to maintain anesthesia; have unpleasant odor and may irritate air passageways; can constantly be monitored |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | neuromuscular junction blocker used as needed for GA; mainly for endotracheal intubation |  | 
        |  | 
        
        | Term 
 
        | fentanyl, other analgesics |  | Definition 
 
        | used to reduce dose of GAs and specifically block noxious stimulus reflex in autonomic nervous system |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | condition where half-concious pts exhibit restlessness, crying, moaning, and thrashing; pts often have HTN and tachycardia as a result of rebound effect from effects of GAs wearing off |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug given to reduce shivering threshold when coming out of general anesthesia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | avoid these drugs until effects of GAs have worn off |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOST important factor affecting inhaled GAs |  | 
        |  | 
        
        | Term 
 
        | high water solubility = slow induction |  | Definition 
 
        | it takes a long for inhaled GA to first dissolve in blood before entering CNS |  | 
        |  | 
        
        | Term 
 
        | low water solubility = rapid induction |  | Definition 
 
        | inhaled GA is NOT soluble in blood & rapidly goes from blood to CNS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | poorly soluble in blood (partition coefficient = 0.47) AND low lipid solubility --> rapid induction, fast acting, AND not very potent; MAC = 105%; by itself it cannot achieve desired depth of anesthesia; colorless, odorless gas --> used to induce analgesia in dentist office;
 SEs:  middle ear air pockets may expand; depresses ventillary response to hypoxia; does NOT trigger malignant hyperthermia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inaled GA; MAC = 0.75%; MOST POTENT; no pungent odor;
 very soluble in blood (partition coefficient = 2.3)--> slowest induction --> slowest recovery;
 SEs:
 20-25% decrease in BP; vasodilation; decreased CO, bradycardia; decrease renal blood flow; muscle relaxation; decrease ventilation rate; hepatitis
 |  | 
        |  | 
        
        | Term 
 
        | Minimum Alveolar Concentration (MAC) |  | Definition 
 
        | meausres potency; the concentration of inhaled GA needed for 50% of pts to NOT respond to pain |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | MAC is proportional to Lipid Solubility |  | Definition 
 
        | high lipid solubility --> greater potency (MAC); low lipid solubility --> lower potency (MAC) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhaled GA still used in 3rd world countries; cheap & effective; SEs: irritates airways, flammable
 High water AND high lipid solubility = slow-acting AND very potent
 |  | 
        |  | 
        
        | Term 
 
        | MAC for Maintenance of Anesthesia |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhaled GA; major anesthetic in US from 30's to 60's; SEs: "spontaneous combustion" on operating table; highly flammable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhaled GA MAC = 1.6%; sweet odor;
 Partition coeffecient = 1.8 --> slower induction;
 SEs:
 decrease BP, decreased cardiomyocyte contractility, peripheral vasodilation; electrical seizure activity (C/I for epilepsy); muscle relaxation (enhanced with NMJ blockers); decrease in ventilation rate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhaled GA MAC = 1.2%; pungent odor;
 Partition Coefficient = 1.4 --> medium induction;
 >99% eliminated unchanged via lungs;
 SEs: decrease in BP, vasodilation, mild tachycardia, decreased renal blood flow, muscle relaxation (enhanced with NJM blocker)
 Preferred GA for neurosurgery;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhaled GA MAC = 6%;
 irritating gas --> coughing, respiratory secretions, MUST USE IV GA to induce anesthesia;
 Partition coefficient = 0.45 --> rapid induction;
 SEs:
 decreased BP, ventilation rate; tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhaled GA MAC = 2%; reacts with dried out soda lime to produce CO;
 Partition coefficient = 0.65;
 SEs: decreased BP, systemic vasodilation;
 Preferred GA for pts prone to myocardial ischemia;
 Short term renal damage (Compound A formation)
 |  | 
        |  | 
        
        | Term 
 
        | sodium thiopental [Pentothal] |  | Definition 
 
        | IV GA; Induction dose: 3-5 mg/kg;
 Induction time = 1 min
 Duration of action = 5-8 min;;
 Initial drug used in current lethal injection protocol;
 LD50 = 50 mg/kg;
 pH = 10-11 --> drug precipitation if mixed with acidic drugs;
 MoA: barbiturate;
 SEs: decrease brains metabolic rate, decreases BP, vasodilation, decreases heart contractility, decreases ventilation rate; "hangover" effect if injected multiple times
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV GA; induction dose: 1.5-2.5 mg/kg;
 Duration of ACtion: 4-8 min;
 NOT water soluble --> VERY lipid soluble (use w/ caution in pts w/ high triglycerides);
 Most common induction agent;
 LACK of hangover effect;
 Allows pts to be discharged faster, good for outpatient procedures;
 MoA: enhances effects of GABA at GABA-A receptors;
 SEs: MAJOR decrease in BP, vasodilation, decraase in myocardial contractility; decrease in ventilation rate; anti-emetic properties; does NOT cross placenta (safe for pregnant women)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV GA; Induction dose: 0.2-0.4 mg/kg
 Duration of action: 4-8 min
 NOT water soluble;
 Used for pts at risk for hypotension;
 Used for induction & maintenance of anesthesia;
 SEs:
 myoclonic movements (tx w/ benzodiazepines); nausea, vomiting;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV GA; Induction dose: 0.5-1.5 mg/kg;
 Duration of Action: 10-15 min
 WATER SOLUBLE;
 produces PROFOUND analgesia;
 used in military, battlefield;
 MoA: NMDA competetive antagonist, inhibition of Na, K channels;
 SEs: increased cerebral blood flow, EMERGENCE DELIRIUM (1 hr post emergence), hallucinations, vivid dreams, illusions; modest decrease in ventilation, potent bronchodilator; incrrease BP, CO, HR --> risky for pts with hypotension
 |  | 
        |  | 
        
        | Term 
 
        | benzodiazepines - midazolam >>> diazepam > lorazepam |  | Definition 
 
        | can produce anesthesia but at doses that would result in prolonged amnesia & sedation; Give IV, oral, rectal, or IM;
 Uses: Pre-op sedation;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | water soluble benzodiazepine; no pain on injection site; more rapid onset (2 min IV), rapid recovery |  | 
        |  | 
        
        | Term 
 
        | opioids - fentanyl (100x more potent than morphine) |  | Definition 
 
        | potent analgesics; Given at induction for later intubation, initial incision; Minimizes vascular reflex to noxious, painful stimuli;
 SEs: nausea, vomiting; decreased ventilation rate, decreased HR, decrease in BP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 100x more potent than morphine; used in Russian hostage/terrorist actions; duration of action: 30 min; |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | shortest duration of action (10 min) of opioids |  | 
        |  | 
        
        | Term 
 
        | alpha-2 adrenergic agonist - dexmedetomidine |  | Definition 
 
        | approved for sedation in critically ill pts; off label use as GA adjunct; IV use only; useful in non-intubated pts
 |  | 
        |  | 
        
        | Term 
 
        | alpha-2 adrenergic agonist - dexmedetomidine |  | Definition 
 
        | approved for sedation in critically ill pts; off label use as GA adjunct; IV use only; useful in non-intubated pts
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | core body temp < 36 degrees C; due to exposed body cavities, IV fluid at room temp, vasodilation of skin, normal room temp is 21 or colder; Warming efforts:
 heated surgical beds, heat air that is inhaled with GA, water-filled garments with microprocessor control of body temp.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | core body temp reaches 42 degrees C with muscle rigidity; can occur in most GAs and some NJM blockers; Mechanism: ryanodine Ca channels do NOT close --> uncontrolled muscle contraction leading to heat generation --> myocytes lyse releasing K causing fatal cardiac effects;
 Tx: dantrolene (Dantrium) - ryanodine receptor inhibitor, also used to tx muscle spasms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ryanodine receptor inhibitor; also used to treat spasms; used to treat malignant hyperthermia due to GAs |  | 
        |  |